Xue, Wei <br/><br/>
SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors.  [electronic resource] 

 -  Oncotarget  Dec 2016 
 - 83088-83100 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.13070  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Immunological--pharmacology<br/>Cancer Vaccines--immunology<br/>Cell Proliferation--drug effects<br/>Cytotoxicity, Immunologic--drug effects<br/>HLA-DR4 Antigen--genetics<br/>Lymphocyte Activation--drug effects<br/>Lymphocytes, Tumor-Infiltrating--drug effects<br/>Melanoma, Experimental--immunology<br/>Mice, Transgenic<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Skin Neoplasms--immunology<br/>T-Lymphocytes--drug effects<br/>Time Factors<br/>Tumor Microenvironment<br/>Vaccines, DNA--immunology